Brian Skorney analyst BAIRD

Currently out of the existing stock ratings of Brian Skorney, 258 are a BUY (73.5%), 81 are a HOLD (23.08%), 12 are a SELL (3.42%).

Brian Skorney

Work Performance Price Targets & Ratings Chart

Analyst Brian Skorney, currently employed at BAIRD, carries an average stock price target met ratio of 65.49% that have a potential upside of 50.85% achieved within 293 days.

Brian Skorney’s has documented 716 price targets and ratings displayed on 42 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on MIRM, Mirum Pharmaceuticals at 08-Dec-2025.

Wall Street Analyst Brian Skorney

Analyst best performing recommendations are on APLT (APPLIED THERAPEUTICS).
The best stock recommendation documented was for APLT (APPLIED THERAPEUTICS) at 1/8/2020. The price target of $43 was fulfilled within 1 day with a profit of $7.82 (22.23%) receiving and performance score of 222.29.

Average potential price target upside

ACHN Achillion Pharmaceuticals AIMT Aimmune Therapeutics ALBO Albireo Pharma AMGN Amgen AXON Axon Enterprise BIIB Biogen CELG Celgene CRIS Curis ENTA Enanta Pharmaceuticals GILD Gilead Sciences ICPT Intercept Pharmaceuticals MYOV Myovant Sciences Ltd NBIX Neurocrine Biosciences PRNB Principia Biopharma REGN Regeneron Pharmaceuticals RETA Reata Pharmaceuticals SRPT Sarepta Therapeutics TBPH Theravance Biopharma VRTX Vertex Pharmaceuticals VTGN VistaGen Therapeutics IMVT Immunovant  PTI Proteostasis Therapeutics TTPH Tetraphase Pharmaceuticals VYGR Voyager Therapeutics RPHM Reneo Pharmaceuticals MRNS Marinus Pharmaceuticals APLT Applied Therapeutics CRNX Crinetics Pharmaceuticals INVA Innoviva MIRM Mirum Pharmaceuticals EIGR Eiger Biopharmaceuticals RGNX Regenxbio BHVN Biohaven Pharmaceutical Holding Co Ltd SLNO Soleno Therapeutics ANRO Alto Neuroscience ASMB Assembly Biosciences BGNE BeiGene Ltd BMRN Biomarin Pharmaceutical INSM Insmed ITMN InterMune NERV Minerva Neurosciences DYN Dyne Therapeutics 

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 21-May-2018

$2

$1.82 (1011.11%)

$5

6 years 9 months 20 days ago
(03-May-2019)

2/3 (66.67%)

$-0.96 (-32.43%)

528

Hold Since 04-Nov-2016

$4

8 years 15 days ago
(08-Feb-2018)

4/4 (100%)

$-0.81 (-16.84%)

106

Buy Since 11-Dec-2017

$5

$4.82 (2677.78%)

$6

8 years 2 months 12 days ago
(11-Dec-2017)

0/4 (0%)

$2.14 (74.83%)

Buy Since 15-Sep-2016

$10

8 years 5 months 11 days ago
(12-Sep-2017)

0/2 (0%)

$5.79 (137.53%)

Hold Since 10-Aug-2017

$4

$3.82 (2122.22%)

$5

8 years 5 months 12 days ago
(11-Sep-2017)

6/7 (85.71%)

$0.17 (4.44%)

49

Show more analysts

Please expand the browser size to see the chart

Which stock is Brian Skorney is most bullish on?

Potential upside of $81.64 has been obtained for SLNO (SOLENO THERAPEUTICS)

Which stock is Brian Skorney is most reserved on?

Potential downside of -$17.16 has been obtained for MIRM (MIRUM PHARMACEUTICALS)

What Year was the first public recommendation made by Brian Skorney?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?